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Since the use of robot-assisted laparoscopic prostatectomy 
(RALP) was first reported in 2000, there has been rapid 
adoption of robotic surgery for men with prostate cancer 
(PCa). In the USA, more than 85% of prostatectomies are 
done robotically over open, and although the proportion 
is lower in the UK and Europe, it is increasing (1). Despite 
the cost and inherent minimally invasive advantage of the 
former over the latter this has gone exponential application 
without a strong evidence of benefit overcoming the costs. 
Recently, Yaxley et al. (2), has disclosed that the early 
outcomes of a well conducted prospective randomized trial. 
This has become a ringing bell, which triggered a lot of 
discussion about the flaws and strengths of this revelation 
in the field of urology. This study included of men with 
localized PCa who were electronically randomized to receive 
robot assisted radical prostatectomy (RARP) or open radical 
prostatectomy (ORP). The surgery was performed by a 
young robotic surgeon with 200-case and an experienced 
open surgeon with 1,500 cases. The primary endpoints 
were sexual and urinary function at 6 weeks, 12 weeks, and 
24 months and oncological outcome. Their results showed 
that urinary and sexual function did not significantly differ at 
12 weeks (83.80 vs. 82.50; P=0.48 and 35.00 vs. 38.90; 
P=0.18, respectively). However, RARP took the edge on the 
surgery time, occurrence of intraoperative adverse event, 
blood loss and length of hospital days (P<0.001, P=0.02, 
P<0.001, and P<0.001, respectively). Likewise, patients who 
received RARP had also lower postoperative complications 
(≥grade III) although the p value didn’t reach statistical 
significance (1 vs. 7, P=0.05).
As the saying goes, we should “compare apples to apples”. 
In this study, the incomparable differences between the two 
surgeons made the primary endpoint less measurable. This 
heterogeneity in experience may have brought an impact 
on the recovery of continence and risk of complications 
(3,4). Additionally, lack of generalisability may also be 
brought by short term results because we all know that 
functional outcome is expected to improve between 
12–18 months (5). But looking on the other side of the 
coin, the less experienced surgeon delivered a comparable 
result to a surgeon with robust experience by the robotic 
aide. While we agree to a strong correlation between 
surgeon experience and surgical outcomes, it would also be 
worth stating that a robotic system can potentially fill the 
experience gap. 
Undeniably, RARP arm should also be given credit for 
the preoperative advantages it has shown. This inherent 
advantage of the minimally invasive technique such as 
RARP is still quite worth mentioning like shorter surgery 
time and hospital stay, less blood loss and adverse events, 
and less postoperative complications. This superiority was 
never placed as one of the key messages of this paper but 
rather focused on the importance of surgeon experience 
which lacks proper support from their results. It is perhaps 
likely that with further technological evolutions these 
advantages will be more quantifiable for the patients. 
This incongruent findings from what has been reported 
and thought of before, has brought us a meaningful message 
that this is just the beginning of a new horizon in robotics. 
A tip of the iceberg; as we may say, equality of outcome 
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between open and robotic surgery will trigger further 
innovations and advancements to surpass such. At present 
time, these equivalent outcomes between techniques have 
shown that above all technologies, surgeon and his vast 
experience prevail over them. While everyone awaits for the 
long-term outcome of the contemporary open technique 
and robotic surgery, it might be insightful to also look 
at what is at hand for us. Despite the very well-known 
advantages such as improved vision and better ergonomics, 
robotic technology has also brought a different perspective 
in training of new robotic surgeons (6,7). This in effect 
has translated into lower learning curve due to structured 
courses and simulation exercises without compromising 
patient’s safety. Aside from this, several reports have shown 
promising incorporation of other new technologies in 
the robotic platform. Integration of fluorescence into 
robotic system have shown acceptable outcome without 
any morbidity (8). This enhancement will further facilitate 
lymph node yield which will potentially lead to improved 
oncological outcome. Furthermore, intraoperative 
ultrasound linked to robotic system has also demonstrated 
key anatomical structures and valuable guidance for 
the console surgeon (9). In the future, we might even 
see an artificial intelligence integrated within a robotic 
interface. These innovations together with rapidly evolving 
technologies at hand are all aimed towards one goal which 
is achievement of better treatment outcome.
Unquestionably, one of the major factors why robotic 
surgery hasn’t become the recommended treatment option 
is its cost-effectiveness despite its widespread use. The cost 
that entails in obtaining robot along with consumables 
and maintenance are always part of the hurdle against 
the advantages it offers. Recently, several other robotic 
companies have reported success with different platforms. 
The ALF-X system (SORAR, SpA, Milan, Italy) has boosted 
its specifications having haptic feedback and infra-red eye-
tracking system. Its success in porcine model has now been 
proven to be likewise feasible and effective in gynecologic 
patients (10). Asian countries like South Korea and China 
has also developed their own robotic system. Abdel Raheem 
et al. (11) have reported their success in animal study using 
REVO I robot system (Meree company, Seoul, South 
Korea) and recently commenced with human trials. In 
China, Yi et al. (12) reported safe and effective outcome of 
clinical cases utilizing Micro Hand S System. With these 
potential uprising of other systems, costs effectiveness of 
robotic surgery might no longer be an issue in the future.
At the end of the day, surgeon experience will always 
play a critical role in surgical outcome. Meanwhile, when 
these technologies and enhancements have become readily 
available on the main stream an inevitable paradigm 
shift might be expected. This will help us embrace the 
robotic technology as an evolution of what awaits us in the 
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